Skip to main content
. 2022 May 27;11(6):1060. doi: 10.3390/antiox11061060
AASLD American Association for the Study of Liver Diseases
ACAT1 acyl-CoA: cholesterol acyltransferase 1
ADA American Diabetes Association
AFLD alcoholic fatty liver disease
ALT alanine aminotransferase
ApoE−/− apolipoprotein E-deficient
ASH alcohol-related steatohepatitis
BNP brain natriuretic peptide
CAD coronary artery disease
CI confidence interval
CIDEB cell death-inducing DFFA-like effector b
cIMT carotid–intima media thickness
CK-18 cytokeratine-18
CRP C-reactive protein
CT computed tomography
CV cardiovascular
CVD cardiovascular diseases
CVOTs cardiovascular outcome trials
DAMPs damage-associated molecular patterns
DNL de novo lipogenesis
DPP-4i dipeptidyl dipeptidase-4 inhibitors
EASD European Association for the study of Diabetes
EASL European Association for the Study of Liver
ECs endothelial cells
eNOS endothelium nitric oxide synthase
ER endoplasmic reticulum
ERK extracellular signal-regulated kinase
FAO fatty acid β-oxidation
FDA Food and Drug Association
FFAs free fatty acids
FibroScan transient elastography
FOXO1 forkhead transcription factor O1
FXRs farnesoid X receptors
GCKR glucokinase regulator
GLP-1 RAs glucagon-like peptide-1 receptor agonists
GPAM glycerol-3-phosphate acyltransferase
GWAS genome-wide association studies
HAECs human aortic endothelial cells
HbA1(c) glycated hemoglobin
HMGB-1 high-mobility group protein 1
hsCRP high-sensitivity c-reactive protein
HSCs hepatic stellate cells
17β-HSD13 hydroxysteroid 17-beta dehydrogenase 13
ICAM-1 intercellular adhesion molecule-1
IL interleukin
JNK c-Jun NH2-terminal kinase
KLF2 Krüppel-like Factor 2
LDLr−/− low-density lipoprotein receptor deficient
LOX-1 lectin-like oxLDL receptor-1
Lp(a) lipoprotein (a)
MACE major adverse cardiovascular event
MBOAT7 membrane-bound O-acyltransferase domain-containing 7
MCP-1 monocyte chemoattractant protein-1
MetS metabolic syndrome
MMPs matrix metalloproteinases
MRI magnetic resonance imaging
NAFLD nonalcoholic fatty liver disease
NAS NAFLD activity score
NASH nonalcoholic steatohepatitis
NASH CRN NASH Clinical Research Network
NCEH neutral cholesterol ester hydrolase
NK natural killer
NLRP3 NOD-like receptor protein 3
NLRs NOD-like receptors
oxLDL oxidized low-density lipoprotein
PAI-1 plasminogen activator inhibitor-1
PAMPs pathogen-associated molecular patterns
PDFF proton density fat fraction
PDGF platelet-derived growth factor
PNPLA3 patatin-like phospholipase domain-containing 3
PRRs pattern recognition receptors
PUFAs polyunsaturated fatty acids
PYGO1 Pygopus family PHD finger 1
ROS reactive oxygen species
SCFAs short-chain fatty acids
SR scavenger receptor
T2DM type 2 diabetes mellitus
TGF-β1 transforming growth factor
TGR5 G-protein-coupled receptor 5
TGs triglycerides
TIMP-1 tissue inhibitor of metalloproteinases 1
TIMPs tissue inhibitor of metalloproteinases
TLRs toll-like receptors
TM6SF2 transmembrane 6 super-family member 2
TNF-a tumor necrosis factor-a
VCAM-1 vascular cell adhesion molecule
VLDL very low density lipoproteins
VSMC vascular smooth muscle cells